DouglasBoyerMuchmoreMD
Endocrinology • La Jolla, CADiabetes, Lipid Metabolism
VP, Endocrinolgoy Clinical Development, Halozyme Therapeutics, Inc
Dr. Muchmore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
7037 Via Valverde
La Jolla, CA 92037Phone+1 858-704-8289- Is this information wrong?
Education & Training
University of California San Diego School of MedicineClass of 1975
University of Oklahoma Health Sciences CenterFellowship, Endocrinology, Diabetes, and Metabolism
Certifications & Licensure
CA State Medical License 1977 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Safety Study of Subcutaneously-Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes Mellitus Start of enrollment: 2009 May 01
- Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus Start of enrollment: 2010 Aug 01
- Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 13 citationsDivergent Hypoglycemic Effects of Hepatic-Directed Prandial Insulin: A 6-Month Phase 2b Study in Type 1 Diabetes.David C. Klonoff, Bruce W. Bode, Nathan J. Cohen, Marc S. Penn, W. Blair Geho, Douglas B. Muchmore> ;Diabetes Care. 2019 Sep 11
- 8 citationsSubcutaneous Insulin Administration: Sufficient Progress or Ongoing Need?Ronald J. Pettis, Douglas B. Muchmore, Lutz Heinemann> ;Journal of Diabetes Science and Technology. 2019 Jan 1
- 6 citationsRecombinant Human PH20: Baseline Analysis of the Reactive Antibody Prevalence in the General Population Using Healthy Subjects.Sanna Rosengren, Jennifer Souratha, Dave Conway, Douglas B. Muchmore, Barry J. Sugarman> ;Biodrugs. 2018 Feb 1
- Join now to see all
Press Mentions
Diasome’s Liver Targeted InsulinApril 18th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
